Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study

Polyxeni Nicolaidou1, Helen Georgouli, Haralambos Kotsalis

  • 1Third Pediatric Department, Athens University, Athens, Greece. pedatt@med.uoa.gr

Insights

Anticonvulsant drugs like carbamazepine and sodium valproate can lead to vitamin D deficiency in children. This study found a significant decrease in vitamin D levels and a rise in parathyroid hormone during treatment.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Pharmacology
  • Neurology

Background:

  • Conflicting reports exist regarding the association between anticonvulsant medications and hypovitaminosis D in pediatric populations.
  • Vitamin D deficiency can have significant implications for bone health and overall well-being in children.

Purpose of the Study:

  • To prospectively evaluate the impact of carbamazepine and sodium valproate on vitamin D status in ambulatory epileptic children.
  • To assess changes in serum 25-hydroxyvitamin D, parathyroid hormone, calcium, and phosphorus levels during anticonvulsant therapy.

Main Methods:

  • A prospective study involving 51 epileptic children treated with carbamazepine or sodium valproate over three years.
  • Serum levels of 25-hydroxyvitamin D, parathyroid hormone, calcium, and phosphorus were measured at baseline and every three months.
  • Patients were grouped based on treatment duration, and comparisons were made with a control group of 80 healthy children.

Main Results:

  • No significant differences in vitamin D or related parameters were observed between controls and patients before treatment.
  • A statistically significant decreasing trend in serum 25-hydroxyvitamin D (P < .03) and an increasing trend in serum parathyroid hormone (P < .04) were noted from baseline through three years of treatment.
  • Nearly half (49%) of the pediatric patients developed hypovitaminosis D during the study period.

Conclusions:

  • Carbamazepine and sodium valproate therapy are associated with the development of hypovitaminosis D in children.
  • The findings highlight the need for monitoring vitamin D status in pediatric patients receiving these anticonvulsant medications.

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...